GLP-1 RAs can reduce body weight, which are particularly beneficial for T2DM patients accompanied with obesity.[12] Semaglutide is generally used as an adjunctive to diet and exercise treatment in T2DM. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.